A · TOPICAL PLATFORMS
Foam · gel · cream · spray · lacquer · film
Six vehicle chassis, each tuned for a specific tissue target — scalp follicles, inflamed skin, nail plates, mucosa, vessels below the dermis.
STUDIO / COMPANY FILEA DERMATOLOGICAL PHARMACEUTICALS HOUSE
Focused,
on purpose.
Xhealth Products develops and supplies pharmaceutical products for dermatological, topical and transdermal use. Our portfolio is built around practical patient needs: effective local delivery, tolerable long-term use, and formats that fit real everyday treatment routines.
§ 01 — WHO WE ARE
A house with one obsession.
We combine advanced pharmaceutical technology with skin science to design formulations that deliver visible, long-lasting results while respecting skin health. Our team includes formulation chemists, dermatologists, regulatory specialists and pharmacovigilance officers — all pointed at the same layer of tissue.
The company is deliberately narrow. We do not make chewing gum or vitamins. We do not chase novelty molecules whose delivery hasn't been solved. We take actives that are already known to work, and build them into vehicles that finally let them.
§ 02 — CAPABILITIES
Where our
capabilities are strongest.
B · SKIN & SCALP DELIVERY
Local exposure, targeted release
Minoxidil foam and finasteride scalp spray reflect our emphasis on targeted application, rapid drying, good spreadability and reduced daily treatment burden.
C · MULTI-CONDITION
Six therapeutic areas
Androgenetic alopecia, hyperpigmentation, acne, scars, tinea, onychomycosis, haemorrhoids, superficial vascular discomfort and selected men's health.
D · USABILITY
Patient-centred formats
Non-greasy foams, precise sprays, elegant creams, durable nail lacquers, gel systems designed to sit on skin as a comfortable protective layer.
§ 03 — METHOD
From active ingredients
to clinically usable products.
Our core strength is turning established pharmaceutical actives into optimised local products. We combine skin science, vehicle selection, penetration enhancement and tolerability design so that treatments can act where they are needed while remaining practical for repeated use.
The same know-how supports our future work in advanced dermal and transdermal delivery — including systems for actives previously deemed undeliverable due to molecular weight, hydrophobicity or bioavailability.
01
6+
Major topical dosage formats
02
8
Priority therapeutic fields
03
One focus · skin-accessible care
Everything we do sits within one arm's reach of the patient's skin.
§ 04 — VISION
A trusted leader in innovative
dermatological healthcare.
Improving skin health and quality of life for patients through science, safety, and excellence — with a portfolio built on evidence, not marketing.
MISSION · IN THREE LINES
- 01Develop and distribute clinically proven skincare and topical products that address unmet medical needs.
- 02Advance formulations and delivery technologies that enhance efficacy, safety, and patient compliance.
- 03Partner with global manufacturers and healthcare professionals for responsible, patient-centric access.
